Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hipofiza in hypothalamic hormoni in analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
stimufend
fresenius kabi deutschland gmbh - pegfilgrastim - nevtropenija - immunostimulants, , colony stimulating factors - skrajšanje trajanja nevtropenija in pojavnost vročinskih nevtropenija pri odraslih bolnikih, zdravljenih s citotoksično kemoterapijo za malignosti (razen kronično mieloično levkemijo in mielodisplastični sindrom).
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
qaialdo
nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 in 5.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
lacosamide adroiq
extrovis eu ltd. - lakosamid - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
talvey
janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
Slovenia -
Slovenia -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
simvastatin lek 10 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 10 mg / 1 tableta - simvastatin
Slovenia -
Slovenia -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
simvastatin lek 10 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 10 mg / 1 tableta - simvastatin
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
novorapid
novo nordisk a/s - insulin aspart - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - novorapid je indiciran za zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 1 leto in več.
Slovenia -
Slovenia -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
zypsila 20 mg trde kapsule
krka, d.d., novo mesto - ziprasidon - kapsula, trda - ziprasidon 20 mg / 1 kapsula - ziprasidon
Slovenia -
Slovenia -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
zypsila 20 mg trde kapsule
krka, d.d., novo mesto - ziprasidon - kapsula, trda - ziprasidon 20 mg / 1 kapsula - ziprasidon